• Home
  • Startups & IPO
  • Shri Ahimsa Naturals Soars 17.6% on NSE SME Debut, Opening at ₹140: A Bumper Stock Performance!
Shri Ahimsa Naturals Soars 17.6% on NSE SME Debut, Opening at ₹140: A Bumper Stock Performance!

Shri Ahimsa Naturals Soars 17.6% on NSE SME Debut, Opening at ₹140: A Bumper Stock Performance!

Shri Ahimsa Naturals Makes a Splash with Impressive IPO Launch

Today marked a significant milestone for Shri Ahimsa Naturals, as the company’s shares made a stunning debut on the NSE SME platform. Opening at ₹140, the stock soared 17.6% above its issue price of ₹119, showcasing strong investor interest right from the start.

IPO Subscription and Performance

The Shri Ahimsa Naturals IPO opened for subscription on March 25 and concluded on March 27. With a fixed price band between ₹113 and ₹119 per share, the IPO has attracted considerable attention, achieving a remarkable subscription rate of 62.71 times by the end of its third day, according to data from Chittorgarh.com. Investors were able to bid for a minimum of 1,200 equity shares, with additional shares available in multiples of this amount.

Company Overview and Product Range

Founded in 1990, Shri Ahimsa Naturals specializes in the extraction and production of key ingredients such as Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. The company also trades in a variety of herbal extracts, which are increasingly popular in the food and beverage, nutraceutical, cosmetics, and pharmaceutical sectors due to their numerous health benefits. Their diverse product lineup includes Natural Caffeine and Green Coffee Bean Extract.

Shri Ahimsa Naturals exports its high-quality products to several countries, including the USA, Germany, South Korea, UK, and Thailand. For the fiscal year ending September 30, 2024, the company reported significant export revenues amounting to ₹3,530.91 lakhs for fiscal year 2023, up from ₹5,633.50 lakhs in fiscal year 2022.

IPO Details and Fund Allocation

See also  CoreWeave IPO: Nvidia-Backed AI Startup Valued at $23 Billion—What It Means for the Future of US IPOs

The IPO consists of a fresh issue of shares valued at up to ₹50.02 crore, alongside an offer for sale (OFS) of 1,999,200 equity shares by a promoter selling shareholder. The proceeds from this IPO will be allocated for various purposes, including investments in Shri Ahimsa Healthcare Private Limited, aimed at establishing a new manufacturing facility in Sawarda, Jaipur, Rajasthan, as well as for general corporate expenditures.

Market Insights and Grey Market Premium

As of today, the grey market premium (GMP) for Shri Ahimsa Naturals shares stands at +19.5, indicating strong market enthusiasm. This suggests that the shares are trading at a premium of ₹19.5 in the grey market, hinting at a projected listing price of approximately ₹138.5, which is 16.39% higher than the IPO price. Notably, the grey market has shown a consistent upward trend over the past 15 days, with the minimum GMP recorded at ₹0.00 and the maximum reaching ₹22.00, further reflecting investor confidence.

With the impressive debut and robust subscription figures, Shri Ahimsa Naturals is poised for a promising future in the stock market. As they continue to expand their footprint both domestically and internationally, the company remains a key player in the health and wellness sector.

Related Post

Retaggio Industries IPO Allotment Today: Latest GMP Insights & 4 Easy Steps to Check Your Status!
Retaggio Industries IPO Allotment Today: Latest GMP Insights & 4 Easy Steps to Check Your Status!
ByAbhinandanApr 3, 2025

Retaggio Industries has finalized its IPO share allotment today, allowing investors to check their status…

Exciting News: Modern Diagnostic Submits DRHP for SME IPO at BSE – Everything You Need to Know!
Exciting News: Modern Diagnostic Submits DRHP for SME IPO at BSE – Everything You Need to Know!
ByAbhinandanApr 2, 2025

Modern Diagnostic & Research Centre Ltd, a Gurugram-based pathology and imaging company, has submitted its…

Bollywood Film Earns ₹65 Lakh, Sets Stage for ₹3,500 Crore IPO: Here's the Inside Scoop!
Bollywood Film Earns ₹65 Lakh, Sets Stage for ₹3,500 Crore IPO: Here’s the Inside Scoop!
ByAbhinandanApr 1, 2025

On March 27, Indira IVF withdrew its Initial Public Offering (IPO) following concerns from the…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!